Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-7.2%
5Y CAGR+20.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.2%/yr
Annual compound
5Y CAGR
+20.7%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.6x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $93.33M | -13.2% |
| 2024 | $107.48M | -12.3% |
| 2023 | $122.51M | +4.8% |
| 2022 | $116.91M | +70.0% |
| 2021 | $68.78M | +88.8% |
| 2020 | $36.43M | +31.5% |
| 2019 | $27.71M | - |